 |
 |
院長：牧田 善二
Doctor: Zenji Makita |
|
|
 |
研究の業績
| 発表年 |
種別 |
タイトル・掲載の詳細 |
| 2002年 |
原著 |
65) Yamagishi S, Amano S, Inagaki Y, Okamoto T, Koga K, Sasaki N, Yamamoto H, Takeuchi M, Makita Z : Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal Pericytes. Biochem Biophysical Res Commun 290:973-978, 2002
|
| |
総説 |
54) 古賀康八郎、山岸昌一、 牧田善二 ：糖尿病の非薬物療法の基本 . 大道学館出版部 臨床と研究 79:35-37, 2002 |
| |
著書 |
32) |
| |
原著 |
66)Okamoto T, Tanaka S, Stan AC, Koike T, Kase M, Makita Z , Sawa H, Nagashima K.
Advanced glycation end products induce angiogenesis in vivo.
Microvasc Res. 2002 Mar;63(2):186-95. |
| |
原著 |
67)Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, Makita Z.
Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
J Biol Chem. 2002 Jun 7;277(23):20309-15. |
| |
原著 |
68)Sasaki N, Takeuchi M, Chowei H, Kikuchi S, Hayashi Y, Nakano N, Ikeda H, Yamagishi S, Kitamoto T, Saito T, Makita Z.
Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.
Neurosci Lett. 2002 Jun 28;326(2):117-20. |
| |
原著 |
69)Schwab W, Friess U, Hempel U, Schulze E, Makita Z , Kasper M, Simank HG.
Immunohistochemical demonstration of -(carboxymethyl)lysine protein adducts in normal and osteoarthritic cartilage.
Histochem Cell Biol. 2002 Jun;117(6):541-6. |
| |
原著 |
70)Yamagishi S, Okamoto T, Amano S, Inagaki Y, Koga K, Koga M, Choei H, Sasaki N, Kikuchi S, Takeuchi M, Makita Z.
Palmitate-induced apoptosis of microvascular endothelial cells and pericytes.
Mol Med. 2002 Apr;8(4):179-84. |
| |
原著 |
71)Miyoshi H, Taguchi T, Sugiura M, Takeuchi M, Yanagisawa K, Watanabe Y, Miwa I, Makita Z , Koike T.
Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.
Horm Metab Res. 2002 Jul;34(7):371-7. |
|
|
